SCI
IRWD icon

S&CO Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

S&CO Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-45,999
Closed -$612K – 183
2016
Q3 		$612K Sell
45,999
-1,970
-4% -$23K 0.09% 112
2016
Q2 		$525K Sell
47,969
-16,955
-26% -$166K 0.08% 113
2016
Q1 		$595K Sell
64,924
-48,954
-43% -$404K 0.1% 107
2015
Q4 		$1.1M Buy
113,878
+9,433
+9% +$91.2K 0.19% 83
2015
Q3 		$911K Buy
104,445
+12,238
+13% +$114K 0.16% 93
2015
Q2 		$931K Buy
92,207
+12,418
+16% +$144K 0.14% 94
2015
Q1 		$1.07M Buy
79,789
+7,224
+10% +$94.8K 0.15% 87
2014
Q4 		$931K Buy
72,565
+2,537
+4% +$29K 0.14% 92
2014
Q3 		$760K Buy
70,028
+18,686
+36% +$214K 0.12% 94
2014
Q2 		$659K Buy
51,342
+3,582
+8% +$39K 0.09% 96
2014
Q1 		$493K Hold
47,760
– – 0.07% 103
2013
Q4 		$464K Buy
47,760
+23,880
+100% +$214K 0.08% 100
2013
Q3 		$237K Hold
23,880
– – 0.04% 115
2013
Q2 		$199K Buy
+23,880
New +$289K 0.03% 119

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

S&CO Inc's IRWD Position: Q4 2016 in Review

S&CO Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2016, closing a stake of 45,999 shares — an estimated $612K sold.

S&CO Inc first reported a position in IRWD in Q2 2013 and held it in 14 quarters. The position peaked at $1.1M in Q4 2015. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • S&CO Inc reported no remaining Ironwood Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • S&CO Inc sold 45,999 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $612K.
  • S&CO Inc first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • S&CO Inc's Ironwood Pharmaceuticals position peaked at $1.1M in Q4 2015.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on S&CO Inc's 13F filing for Q4 2016, filed 25 Jan 2017.